Sovaldi
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
61958-1503 -
Package NDC
61958-1503-1 -
Application number
NDA204671 -
SPL ID
74c52ec6-8358-4e63-b299-64ec1ff7f434 -
SPL set ID
80beab2c-396e-4a37-a4dc-40fdb62859cf -
UNII
WJ6CA3ZU8B -
RxCUI
1484916 -
RxCUI
1484922 -
RxCUI
2203891 -
RxCUI
2203893 -
RxCUI
2203993 -
RxCUI
2203999 -
RxCUI
2204090 -
RxCUI
2204092
What the source publishes
- Labeler
- Gilead Sciences, Inc.
- Active ingredients
- SOFOSBUVIR
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Sovaldi",
"splId": "74c52ec6-8358-4e63-b299-64ec1ff7f434",
"labels": [
{
"setId": "80beab2c-396e-4a37-a4dc-40fdb62859cf",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=80beab2c-396e-4a37-a4dc-40fdb62859cf",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=80beab2c-396e-4a37-a4dc-40fdb62859cf"
}
],
"routes": [
"ORAL"
],
"labeler": "Gilead Sciences, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "28 TABLET, FILM COATED in 1 BOTTLE (61958-1503-1)",
"package_ndc": "61958-1503-1",
"identifierStatus": "well-formed",
"marketing_start_date": "20190828"
}
],
"productId": "61958-1503_74c52ec6-8358-4e63-b299-64ec1ff7f434",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "61958-1503",
"deaSchedule": null,
"genericName": "SOFOSBUVIR",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "SOFOSBUVIR",
"strength": "200 mg/1"
}
],
"applicationNumber": "NDA204671",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20190828",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000191493",
"N0000191258"
],
"unii": [
"WJ6CA3ZU8B"
],
"rxcui": [
"1484916",
"1484922",
"2203891",
"2203893",
"2203993",
"2203999",
"2204090",
"2204092"
],
"spl_set_id": [
"80beab2c-396e-4a37-a4dc-40fdb62859cf"
],
"pharm_class_epc": [
"Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]"
],
"pharm_class_moa": [
"RNA Replicase Inhibitors [MoA]"
],
"manufacturer_name": [
"Gilead Sciences, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:61958-1503_74c52ec6-8358-4e63-b299-64ec1ff7f434"